Pro: Antifibrinolytics are safe and effective in patients undergoing liver transplantation.
Lerner
Adam B
AB
Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Boston, MA, USA. alerner@bidmc.harvard.edu
D000933:Antifibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007611:Aprotinin / Q000009:adverse effects / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control; D005342:Fibrinolysis / Q000187:drug effects; D006490:Hemostatics / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects / Q000379:methods*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control; D016896:Treatment Outcome
D000933:Antifibrinolytic Agents; D006490:Hemostatics; D007611:Aprotinin